Lacosamide toxicity impacting rehabilitation in Moyamoya disease

PM&REarly View CLINICAL LETTER Lacosamide toxicity impacting rehabilitation in Moyamoya disease Stephen Ritter DO, Corresponding Author Stephen Ritter DO [email protected] orcid.org/0000-0002-6453-8905 Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Correspondence Stephen Ritter, Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Email: [email protected]Search for more papers by this authorKaycee Nguyen BS, Kaycee Nguyen BS Texas A&M School of Medicine, Baylor University Medical Center, Dallas, Texas, USASearch for more papers by this authorYousef Darwish MD, Yousef Darwish MD Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USASearch for more papers by this authorNing Cao MD, Ning Cao MD Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USASearch for more papers by this author Stephen Ritter DO, Corresponding Author Stephen Ritter DO [email protected] orcid.org/0000-0002-6453-8905 Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Correspondence Stephen Ritter, Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Email: [email protected]Search for more papers by this authorKaycee Nguyen BS, Kaycee Nguyen BS Texas A&M School of Medicine, Baylor University Medical Center, Dallas, Texas, USASearch for more papers by this authorYousef Darwish MD, Yousef Darwish MD Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USASearch for more papers by this authorNing Cao MD, Ning Cao MD Department of Physical Medicine & Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, Maryland, USASearch for more papers by this author First published: 10 May 2023 https://doi.org/10.1002/pmrj.12993 Written informed consent was obtained. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Update on Antiepileptic Drugs 2019. Abou-Khalil BW. Update on antiepileptic drugs 2019. Continuum (Minneap Minn). 2019; 25(2): 508-536. doi:10.1212/CON.0000000000000715 2Jacob S, Nair AB. An updated overview on therapeutic drug monitoring of recent antiepileptic drugs. Drugs R D. 2016; 16(4): 303-316. doi:10.1007/s40268-016-0148-6 3Malissin I, Baud FJ, Deveaux M, Champion S, Deye N, Megarbane B. Fatal lacosamide poisoning in relation to cardiac conduction impairment and cardiovascular failure. Clin Toxicol. 2013; 51(4): 381-382. doi:10.3109/15563650.2013.778993 4Ng PC, Schimmel J, Wang GS. Lacosamide overdose: a case of QRS prolongation and seizure. J Emerg Med. 2019; 56(6): 652-656. doi:10.1016/j.jemermed.2019.01.018 5Vidaurre J, Gedela S, Yarosz S. Antiepileptic drugs and liver disease. Pediatr Neurol. 2017; 77: 23-36. doi:10.1016/j.pediatrneurol.2017.09.013 6Lattanzi S, Cagnetti C, Foschi N, Provinciali L, Silvestrini M. Lacosamide monotherapy for partial onset seizures. Seizure. 2015; 27: 71-74. doi:10.1016/j.seizure.2015.03.003 7Marcellino C, Ransom CC, Wijdicks EF. Refractory ventricular tachycardia and seizures with Lacosamide overdose. Cureus. 2022; 14(9):e29547. doi:10.7759/cureus.29547 8Markoula S, Teotonio R, Ratnaraj N, Duncan JS, Sander JW, Patsalos PN. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs. Ther Drug Monit. 2014; 36(4): 494-498. doi:10.1097/FTD.0000000000000051 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation